Paula M. Calabro-Jones

Author

University of California San Diego

Also Known As

P Calabro-Jones, P M Calabro-Jones, P. Calabro-Jones, P. M. Calabro-Jones, Paula Calabro-Jones, Paula M. Calabro-Jones

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

University of California San Diego University of California San Diego Medical Center

About

Paula M. Calabro-Jones is an author at University of California San Diego specializing in medicine, pharmacology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	1.1K
2	Cell Biology	3	3	229
3	Engineering	2	2	92
4	Natural Sciences	2	2	204
5	Biochemistry	2	2	204

Paula M. Calabro-Jones

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Pharmacologic requirements for obtaining sensitization of human tumor cells in vitro to combined 5-fluorouracil or ftorafur and X rays John E. Byfield, Paula M. Calabro-Jones, Ivana Klisak, International Journal of Radiation OncologyBiologyPhysics OncologyHuman Tumor CellsRadiation TherapyMedicineAnti-cancer Agent	1982	390
Radiation and hydrogen peroxide induced free radical damage to DNA. John F. Ward, James Evans, Charles L. Limoli, PubMed Radiation ChemistryDna DamageRadiation BiologyRadical (Chemistry)Radiation Effect	1987	179
Alkaline Phosphatase Promotes Radioprotection and Accumulation of WR-1065 in V79-171 Cells Incubated in Medium Containing WR-2721 Paula M. Calabro-Jones, Robert C. Fahey, Geraldine D. Smoluk, International Journal of Radiation Biology and Related Studies in Physics Chemistry and Medicine	1985	168
Uptake of WR-2721 derivatives by cells in culture: identification of the transported form of the drug. Paula M. Calabro-Jones, José Aguilera, John F. Ward, PubMed Pharmaceutical ScienceBioorganic ChemistryCellular PharmacologyChemical BiologyCulture Medium	1988	143
Radioprotection of cells in culture by WR-2721 and derivatives: form of the drug responsible for protection. Geraldine D. Smoluk, Robert C. Fahey, Paula M. Calabro-Jones, PubMed Tumor BiologyRadiation OncologyRadiation MedicineOncologyOncogenic Agent	1988	122
Time-dose relationships for 5-fluorouracil cytotoxicity against human epithelial cancer cells in vitro. Paula M. Calabro-Jones, John E. Byfield, John F. Ward, PubMed Cell Cycle TimeMedicineTime-dose RelationshipsMetronomic TherapyPharmacology	1982	117
Effects of methylated xanthines on mammalian cells treated with bifunctional alkylating agents John P. Murnane, John E. Byfield, John F. Ward, Nature Bifunctional Alkylating AgentsMammalian CellsMedicineToxicologyMethylated Xanthines	1980	76
Carrier-dependent and carrier-independent transport of anti-cancer alkylating agents John E. Byfield, Paula M. Calabro-Jones Nature Medicinal ChemistryPolymer-drug ConjugateCarrier-independent TransportAnti-cancer AgentPharmacology	1981	68
Yield of Strand Breaks as a Function of Scavenger Concentration and LET for SV40 Irradiated with 4 He Ions George D.D. Jones, Jamie R. Milligan, John F. Ward, Radiation Research EngineeringRadiation EffectRadiation ExposureMolecular BiologyDouble-strand Breaks	1993	61
Mice, men, mustards and methylated xanthines: the potential role of caffeine and related drugs in the sensitization of human tumours to alkylating agents J.E. Byfield, John P. Murnane, John F. Ward, British Journal of Cancer Oncogenic AgentMedicinePathologyPotential RoleRadiopharmaceutical Therapy	1981	48

Page 1